India Paracetamol Market to grow at an impressive rate During the Forecast Period
Growing use of paracetamol
as an analgesic and antipyretic agent is expected to drive the growth of India
paracetamol market.
According
to TechSci Research report, “India Paracetamol Market By Source (In-house v/s
Contract Manufacturing Organizations), By Product (Powder v/s Granules), By
Form (Tablet, Capsules, Oral Solution), By Route of Administration (Oral v/s
Intravenous), By Distribution Channel (Online v/s Offline), By Application (Pain & Fever
Reliver, Muscle Cramps, Cold & Cough, Others), By End User (Adult v/s
Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India paracetamol market is expected to grow at an
impressive rate during the forecast period on account of the growing awareness
among the consumers pertaining to pain management. Additionally, paracetamol is
used as an active pharmaceutical ingredient (API) for manufacturing several
generic and OTC drugs. This is expected to positively influence the market
growth through FY2026. Furthermore, the widespread use of paracetamol in
treating a range of conditions including headache, muscle pain, fever,
arthritis, cold and cough, backache, toothache, among others is further
expected to fuel the market growth over the next few years. This in turn has
led to an increase in demand and consumer preference for paracetamol as an over
the counter medication. However, side-effects such as loss of appetite, stomach
pain and low fever with nausea can hamper the market growth over the next five
years. Moreover, in several cases serious side-effects in the form of jaundice
can be observed. Also, in case of chronically alcoholic patients and those
suffering from liver diseases the use of paracetamol should be avoided. This
further slows down the market growth through FY2026.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" India
paracetamol market "
https://www.techsciresearch.com/report/india-paracetamol-market/5139.html
The India paracetamol market is segmented based on source, product,
form, route of administration, distribution channel, application, end user,
company and region. Based on form, the market can be fragmented into tablet,
capsule and oral solution. The tablet segment is expected to dominate the
market during forecast period. This can be attributed to the associated
benefits such as safety, efficacy in delivering oral medications, low cost,
easy availability, among others. On the other hand, capsules have higher drug
absorption and are fast acting. Also, they are tampering resistant and
tasteless. Based on route of administration, the market can be split into oral
and intravenous. The intravenous route of administration is expected to hold a significant
market share owing to its 100% bioavailability and ability to administer a
large dose of a drug. Additionally, this route of administration is helpful in
case of drugs that are not absorbed orally. Based on distribution channel, the
market can be split into online and offline. The offline segment is expected to
dominate the market through FY2026. This can be ascribed to the widespread
network of pharmacies and drug stores where the drug is easily available both
as a prescription medicine and as an OTC drug.
GlaxoSmithKline Pharmaceuticals Ltd., Granules India Limited, Farmson
Pharmaceutical Gujarat Private Limited, Sun Pharmaceutical Industries Ltd., Dr.
Reddy's Laboratories, CFL Pharmaceuticals Limited, Cipla Limited, Sanofi India
Limited, Sri Krishna Pharmaceuticals Limited, Vaishali Pharma Limited and
others are some of the leading players operating in India paracetamol market. Companies operating in the market are using organic
strategies such as product launches, mergers and collaborations to boost their
share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5139
Customers can also request for 10% free customization on
this report.
“India paracetamol market is expected to
witness growth during the forecast period on account of the growing demand for
pain management drug solutions. Additionally, the growing prevalence of
conditions like flu, fever, headache, among others are further expected to
positively influence the market growth. Besides, the versatility, brand value
and consumer faith on the medication are further expected to spur the market
growth over the next few years.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Paracetamol Market By Source (In-house v/s
Contract Manufacturing Organizations), By Product (Powder v/s Granules), By
Form (Tablet, Capsules, Oral Solution), By Route of Administration (Oral v/s
Intravenous), By Distribution Channel (Online v/s Offline), By Application (Pain & Fever Reliver,
Muscle Cramps, Cold & Cough, Others), By End User (Adult v/s Pediatric), By
Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India paracetamol
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India paracetamol market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]